Immune checkpoint inhibitors in cancer therapy

In recent years immune checkpoint inhibitors have garnered attention as being one of the most promising types of immunotherapy on the horizon. There has been particular focus on the immune checkpoint molecules, cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein 1 (PD-1) whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Webb, Eika S., Liu, Peng, Baleeiro, Renato, Lemoine, Nicholas R., Yuan, Ming, Wang, Yaohe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Department of Journal of Biomedical Research 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163118/
https://www.ncbi.nlm.nih.gov/pubmed/28866656
http://dx.doi.org/10.7555/JBR.31.20160168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163118/
https://www.ncbi.nlm.nih.gov/pubmed/28866656
http://dx.doi.org/10.7555/JBR.31.20160168

Ejemplares similares